World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
58
Citations
9139
World Ranking
3503
National Ranking
1381

Kenneth H. Eckels publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Kenneth H. Eckels sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 110 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Kenneth H. Eckels D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth H. Eckels sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 58 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Kenneth H. Eckels is affiliated with the Walter Reed Army Institute of Research in the United States. Their research primarily focuses on infectious diseases, public health, and related medical fields.

The scientist's publication record includes several recent papers with topics related to viral infections, vaccine immunogenicity, and mosquito-borne diseases. Notable papers include:

  • Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor, 2020, Nature Medicine
  • Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial, 2020, The Lancet Infectious Diseases
  • A Phase 1, Open-Label Assessment of a Dengue Virus-1 Live Virus Human Challenge Strain, 2020, The Journal of Infectious Diseases
  • Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial, 2020, The Journal of Infectious Diseases
  • Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine, 2021, Frontiers in Immunology

The scientist frequently publishes within the following venues:

  • The Lancet Infectious Diseases
  • The Journal of Infectious Diseases
  • American Journal of Tropical Medicine and Hygiene
  • Nature Medicine
  • Frontiers in Immunology

Kenneth H. Eckels collaborates regularly with several coauthors, including:

  • Richard G. Jarman
  • Stephen J. Thomas
  • Leyi Lin
  • Michael Koren
  • Kayvon Modjarrad

The main fields of study for this scientist are in Medicine, with specific subfields involving Public Health, Environmental and Occupational Health, Infectious Diseases, Virology, Modeling and Simulation, and Endocrinology.

The core topics covered in their research include:

  • Mosquito-borne diseases and control
  • Malaria Research and Control
  • Viral Infections and Vectors
  • HIV Research and Treatment
  • COVID-19 epidemiological studies
  • Vibrio bacteria research studies
  • Viral Infections and Outbreaks Research

Best Publications

  • Vaccine protection against Zika virus from Brazil

    Rafael A. Larocca;Peter Abbink;Jean Pierre S. Peron;Paolo M. de A. Zanotto

  • Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

    Peter Abbink;Rafael A. Larocca;Rafael A. De La Barrera;Christine A. Bricault

  • Rapid development of a DNA vaccine for Zika virus

    Kimberly A. Dowd;Sung-Youl Ko;Kaitlyn M. Morabito;Eun Sung Yang

  • Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine.

    Robert Edelman;Steven S. Wasserman;Sacared A. Bodison;Robert J. Putnak

  • Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.

    Kayvon Modjarrad;Leyi Lin;Sarah L George;Sarah L George;Kathryn E Stephenson;Kathryn E Stephenson

  • An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.

    J. Robert Putnak;Beth-Ann Coller;Gerald Voss;David W. Vaughn

  • Monoclonal Antibodies Against Dengue 2 Virus E-Glycoprotein Protect Mice Against Lethal Dengue Infection,

    B. M. Kaufman;P. L. Summers;D. R. Dubois;K. H. Eckels

  • Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys

    Robert Putnak;David A. Barvir;Jeanne M. Burrous;Doria R. Dubois

  • Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.

    Wellington Sun;Robert Edelman;Niranjan Kanesa-Thasan;Kenneth H. Eckels

  • Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection

    B. M. Kaufman;P. L. Summers;D. R. Dubois;W. Houston Cohen

  • Production and evaluation of a formalin-killed Chikungunya vaccine.

    V R Harrison;K H Eckels;P J Bartelloni;C Hampton

  • Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes

    T. Hase;P. L. Summers;K. H. Eckels

  • Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults.

    Wellington Sun;Dennis Cunningham;Steven S Wasserman;Judith Perry

  • Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis.

    M. Bray;Bangti Zhao;L. Markoff;K. H. Eckels

  • A purified inactivated Japanese encephalitis virus vaccine made in vero cells

    Ashok K. Srivastava;J.Robert Putnak;Sung H. Lee;Sun P. Hong

  • Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.

    Y M Zhang;E P Hayes;T C McCarty;D R Dubois

  • Safety and Immunogenicity of a Tetravalent Live-attenuated Dengue Vaccine in Flavivirus Naive Children

    Sriluck Simasathien;Stephen J. Thomas;Veerachai Watanaveeradej;Ananda Nisalak

  • A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness.

    V.J. Gunther;R. Putnak;K.H. Eckels;M.P. Mammen

  • Protection of Rhesus Monkeys against Dengue Virus Challenge after Tetravalent Live Attenuated Dengue Virus Vaccination

    Wellington Sun;Ananda Nisalak;Montip Gettayacamin;Kenneth H. Eckels

  • Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development.

    K H Eckels;W E Brandt;V R Harrison;J M McCown

Frequent Co-Authors

Bruce L. Innis
Bruce L. Innis GlaxoSmithKline (United Kingdom)
Richard G. Jarman
Richard G. Jarman Walter Reed Army Institute of Research
David W. Vaughn
David W. Vaughn Bill & Melinda Gates Foundation
Dan H. Barouch
Dan H. Barouch Harvard Medical School
Robert V. Gibbons
Robert V. Gibbons United States Department of the Army
Peter Abbink
Peter Abbink Harvard Medical School
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Robert R. Edelman
Robert R. Edelman Northwestern University
Charles H. Hoke
Charles H. Hoke Walter Reed Army Institute of Research
Michael R. Boyd
Michael R. Boyd National Cancer Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career opportunities beyond traditional lab work. For those interested in healthcare, becoming a functional medicine nurse practitioner offers a specialized pathway that combines microbiology knowledge with patient-centered care. This role requires advanced training but can be highly rewarding for those passionate about integrative health.

Alternatively, the healthcare industry increasingly relies on accurate data management. Earning a professional coder certification enables graduates to manage medical records and billing with precision, supporting the smooth operation of healthcare systems.

For a broader leadership role, a master in health information management salary often reflects the growing demand for professionals who oversee data accuracy, security, and compliance in clinical settings. This degree blends technology and healthcare knowledge, making it a critical career pathway.

Many students pursue these careers through flexible study options, such as an online cahiim accredited health information management degree. Accredited programs ensure high-quality education that aligns with industry standards, preparing graduates for certification and employment success.

Best Scientists Citing Kenneth H. Eckels

Trending Scientists

Recently Published Articles